Kvisselgaard A D, Krøigaard M, Mosbech H F, Garvey L H
Danish Anaesthesia Allergy Centre, Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Acta Anaesthesiol Scand. 2017 Feb;61(2):149-155. doi: 10.1111/aas.12833. Epub 2016 Nov 22.
Local anaesthetics (LA) are often suspected as possible causes of allergic reactions. The Danish Anaesthesia Allergy Centre (DAAC) is the national reference centre for investigation of perioperative allergic reactions. The purpose of this study was to investigate the incidence of IgE-mediated immediate type perioperative allergic reactions to LA.
In the period 2004-2013, a total of 409 patients (244 women/165 men; median age 49 years, range 1-86 years) were investigated in DAAC on suspicion of allergy associated with anaesthesia and surgery. A total of 162 (40%) patients were exposed to one or more LA. Suspected allergy to LA was investigated by prick test, intradermal test and subcutaneous provocation with the suspected drug. Patients with positive skin tests still underwent subcutaneous provocation, as false positive skin tests can occur.
A total of 203 test series with LA were carried out on 162 patients (89 women/73 men; mean age 49 years, range 2-85 years) with the following drugs: Lidocaine n = 80 (49%), bupivacaine n = 82 (51%), ropivacaine n = 31 (19%) and mepivacaine n = 10 (6%). All 162 patients had negative subcutaneous provocation for all tested LA (95% CI: 0-1.8%). Investigations revealed another allergen in 52 of 162 patients.
None of the 162 patients with suspected perioperative allergic reactions and exposure to LA reacted on subcutaneous provocation with the relevant LA. Thus, no patients have been diagnosed with allergy to LA in DAAC in the period 2004-2013 and allergy to LA must be considered very rare in this population.
局部麻醉药(LA)常被怀疑是过敏反应的可能原因。丹麦麻醉过敏中心(DAAC)是围手术期过敏反应调查的国家参考中心。本研究的目的是调查围手术期IgE介导的对LA速发型过敏反应的发生率。
在2004年至2013年期间,共有409例患者(244例女性/165例男性;年龄中位数49岁,范围1至86岁)因怀疑与麻醉和手术相关的过敏反应而在DAAC接受调查。共有162例(40%)患者接触过一种或多种LA。通过点刺试验、皮内试验和用可疑药物进行皮下激发试验来调查对LA的疑似过敏。皮肤试验呈阳性的患者仍需进行皮下激发试验,因为可能会出现假阳性皮肤试验。
对162例患者(89例女性/73例男性;平均年龄49岁,范围2至85岁)进行了总共203次LA试验系列,使用的药物如下:利多卡因n = 80(49%),布比卡因n = 82(51%),罗哌卡因n = 31(19%),甲哌卡因n = 10(6%)。所有162例患者对所有测试的LA皮下激发试验均为阴性(95%可信区间:0至1.8%)。调查发现162例患者中有52例存在另一种过敏原。
162例疑似围手术期过敏反应且接触过LA的患者,在使用相关LA进行皮下激发试验时均无反应。因此,在2004年至2013年期间,DAAC没有诊断出对LA过敏的患者,在该人群中对LA过敏必须被视为非常罕见。